Konishi M, Saito K, Numata K, Tsuno T, Asama K
J Antibiot (Tokyo). 1977 Oct;30(10):789-805. doi: 10.7164/antibiotics.30.789.
The structures of tallysomycins A and B, two major components of a new antitumor antibiotic complex, have been determined. They are glycopeptide antibiotics structurally related to bleomycin: four amino acid moieties and a disaccharide fragment which are the constituents of bleomycin molecule are also present in the tallysomycins. Tallysomycins A and B contain two new amino acids and a unique amino sugar, 4-amino-4,6-dideoxy-L-talose, which have not been hitherto found in the phleomycin-bleomycin group of antibiotics. In addition tallysomycin A has an additional amino acid, L-beta-lysine, and thus a longer peptide chain than bleomycin or tallysomycin B. Tallysomycins A and B have the same terminal amine moiety, spermidine.
一种新型抗肿瘤抗生素复合物的两个主要成分 tallysomycins A 和 B 的结构已被确定。它们是与博来霉素结构相关的糖肽抗生素:博来霉素分子的组成成分中的四个氨基酸部分和一个二糖片段也存在于 tallysomycins 中。Tallysomycins A 和 B 含有两种新氨基酸和一种独特的氨基糖,4-氨基-4,6-二脱氧-L-塔罗糖,这在以前的平阳霉素-博来霉素类抗生素中尚未发现。此外,tallysomycin A 还有一个额外的氨基酸,L-β-赖氨酸,因此其肽链比博来霉素或 tallysomycin B 更长。Tallysomycins A 和 B 具有相同的末端胺部分,即亚精胺。